Two similar commercial live attenuated AMPV vaccines prepared by random passage of the identical field isolate, have unrelated sequences

Vaccine - Tập 37 - Trang 2765-2767 - 2019
Andrea Laconi1, Elena Catelli2, Mattia Cecchinato3, Clive J. Naylor1
1Department of Infection Biology, University of Liverpool, Leahurst Campus, Neston, Cheshire CH64 7TE, United Kingdom
2Department of Veterinary Medical Sciences – University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano dell’Emilia (BO), Italy
3Department of Animal Medicine, Production and Health, University of Padua, Viale dell’università, 16, 35020 Legnaro, PD, Italy

Tài liệu tham khảo

Cook, 1989, A live attenuated turkey rhinotracheitis virus vaccine. 1. Stability of the attenuated strain, Avian Pathol, 18, 511, 10.1080/03079458908418623 Williams, 1991, Development of a live attenuated vaccine against turkey rhinotracheitis, Avian Pathol, 20, 45, 10.1080/03079459108418740 Catelli, 2009, Field avian Metapneumovirus evolution avoiding vaccine induced immunity, Vaccine, 28, 916, 10.1016/j.vaccine.2009.10.149 Catelli, 2006, Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine, Vaccine, 24, 6476, 10.1016/j.vaccine.2006.06.076 Lupini, 2011, A turkey rhinotracheitis outbreak caused by the environmental spread of a vaccine-derived avian metapneumovirus, Avian Pathol, 40, 525, 10.1080/03079457.2011.607428 Listorti, 2017, Lupini C, Naylor CJ. Identification of IBV QX vaccine markers: should vaccine acceptance by authorities require similar identifications for all live IBV vaccines?, Vaccine, 35, 5531, 10.1016/j.vaccine.2017.06.021 Cecchinato, 2014, Reversion to virulence of a subtype B avian metapneumovirus vaccine: Is it time for regulators to require availability of vaccine progenitors?, Vaccine, 32, 4660, 10.1016/j.vaccine.2014.06.030 Jones, 1986119, Demonstration of a candidate virus for turkey rhinotracheitis in experimentally inoculated turkeys, Vet Rec, 599, LP-600 Wilding, 1986118, Ciliostatic agent found in rhinotracheitis, Vet Rec, 735, LP-735 Naylor, 1994, Demonstration of a virulent subpopulation in a prototype live attenuated turkey rhinotracheitis vaccine, Vaccine, 12, 1225, 10.1016/0264-410X(94)90248-8 Naylor, 2007, Avian metapneumovirus SH gene end and G protein mutations influence the level of protection of live-vaccine candidates, J Gen Virol, 88, 1767, 10.1099/vir.0.82755-0 Brown, 2011, A single polymerase (L) mutation in avian metapneumovirus increased virulence and partially maintained virus viability at an elevated temperature, J Gen Virol, 92, 346, 10.1099/vir.0.026740-0 Herfst, 2011, Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle, J Virol, 85, 12650, 10.1128/JVI.05485-11 Yun, 2015, Trypsin- and low pH-mediated fusogenicity of avian metapneumovirus fusion proteins is determined by residues at positions 100, 101 and 294, Sci Rep, 5, 15584, 10.1038/srep15584